Sinopharm Group (China National Pharmaceutical Group Co.)

The products offered by China National Pharmaceutical Group Co. are extensive and cover a wide spectrum of pharmaceuticals, medical devices, healthcare services, and related goods and solutions. These offerings are typically delivered through its vast network of specialized subsidiaries, research institutes, manufacturing plants, distribution centers, retail pharmacies, and healthcare institutions across China and internationally. Key areas of business and their products/services include:

• Pharmaceutical Manufacturing: This is a core business area, encompassing the research, development, and large-scale production of a wide range of pharmaceutical products. Sinopharm is a major manufacturer across different pharmaceutical categories:

  • Biopharmaceuticals: Including vaccines (Sinopharm is one of the world's largest vaccine producers, notably for its COVID-19 vaccines), blood products, antibody drugs, and products for medical aesthetics.
  • Chemical Pharmaceuticals: Manufacturing of Western medicines, including active pharmaceutical ingredients (APIs) and finished drug products covering various therapeutic areas such as anti-infectives, cardiovascular drugs, anesthetics, psychiatric drugs, and anti-cancer drugs.
  • Modern Traditional Chinese Medicine (TCM): Research, development, and production of modernized forms of traditional Chinese medicine, including instant granules and various TCM preparations.
  • Pharmaceutical Raw Materials and Intermediates: Production of APIs and intermediate chemicals used in the synthesis of pharmaceutical drugs.

• Pharmaceutical Commercial Circulation (Distribution and Logistics): This is a major business segment, making Sinopharm a leading distributor of pharmaceuticals and healthcare products in China. Services include:

  • Wholesale Distribution: Distributing pharmaceuticals, medical devices, and healthcare products to hospitals, clinics, pharmacies, and other healthcare institutions across an extensive nationwide logistics network.
  • Logistics and Supply Chain Management: Providing specialized warehousing, transportation, cold chain logistics, and supply chain management services tailored for the pharmaceutical and healthcare industries, ensuring the safe and efficient delivery of sensitive products.
  • Import and Export Trade: Engaging in the international trade of pharmaceuticals, medical devices, raw materials, and healthcare products.

• Retail Pharmacy Chains: Sinopharm operates one of the largest retail pharmacy networks in China. This includes:

  • Retail Drug Stores: Managing a vast chain of retail pharmacies (both directly operated and franchised) selling prescription drugs, over-the-counter (OTC) medications, and other healthcare products directly to consumers. These pharmacies provide convenient access to medicines for the public.

• Medical Devices Business: The group is involved in the development, manufacturing, and distribution of medical equipment and devices. This includes:

  • Medical Equipment: Providing a range of medical equipment for hospitals and clinics, from basic medical instruments to advanced imaging equipment, laboratory equipment, operating room and ICU equipment, and blood purification devices. They are increasingly focusing on high-end and intelligent medical equipment.
  • Medical Consumables: Manufacturing and distribution of medical consumables and supplies used in healthcare settings.
  • In Vitro Diagnostics (IVD): Development and provision of diagnostic reagents and equipment for laboratory testing.

• Healthcare Services: Sinopharm is a significant provider of direct medical and healthcare services. This includes:

  • Hospital Management and Operation: Investing in, managing, and operating a network of hospitals across China, including large general hospitals and specialized clinics (e.g., in areas like stomatology,妇幼 health, medical aesthetics, and blood purification).
  • Clinic Operations: Operating outpatient clinics and specialized treatment centers.
  • Healthcare Management Services: Providing management and consulting services for healthcare institutions.

• Life and Health Protection (Great Health Industry): This segment focuses on products and services related to general health, wellness, and senior care. It includes:

  • Health Products: Developing and marketing a wide variety of health products, nutritional supplements, and functional foods.
  • Medical Aesthetics Services and Products: Providing medical aesthetics services and related products.
  • Senior Care Services: Developing and providing integrated medical and aging care services, including nursing facilities and healthcare bases for the elderly.

• Professional Support and Technology: Sinopharm provides various supporting services and invests in technology and R&D across its businesses:

  • Engineering and Technical Services: Offering engineering, design, construction, and technical services for pharmaceutical manufacturing facilities, hospitals, and other healthcare infrastructure.
  • Supply Chain Technology: Developing and utilizing advanced logistics and supply chain management technologies.
  • Research and Development: Conducting extensive R&D across all its business areas, including drug discovery, vaccine development, medical technology innovation, and digital health solutions, through a network of national-level research institutes and platforms.
  • Financial Services: Providing financial services that support the group's operations and potentially other entities in the healthcare ecosystem, such as investment and financing services.
  • Exhibition and Event Services: Organizing professional exhibitions and events for the pharmaceutical and healthcare industries.

Sinopharm operates as a strategic national platform, playing a critical role in ensuring the accessibility of medicines and healthcare products across China, including fulfilling national mandates for public health safety and emergency supply. Its vast scale and integrated structure allow it to cover the entire pharmaceutical and healthcare value chain, from the research bench to the patient.

In summary, China National Pharmaceutical Group Co. (Sinopharm) is a large central state-owned enterprise in China whose actual business is the comprehensive development, manufacturing, distribution, retail, and provision of pharmaceuticals, medical devices, healthcare services, and related products and solutions across the entire pharmaceutical and healthcare value chain. Its function is to serve as a national leader and integrated provider in the life sciences and healthcare ecosystem, ensuring public health safety and advancing the industry's capabilities. The "products" it offers are its wide range of pharmaceutical and biopharmaceutical products (including vaccines), medical devices and consumables, a vast portfolio of healthcare services provided through its institutions, a nationwide pharmaceutical distribution and retail network, and various related technical, financial, and support services.